Effect of obesity, glucose control, lipid profiles, and blood pressure on Lp-PLA2 levels in type 2 diabetes mellitus patients-Reference-Cited by-同舟云学术

Effect of obesity, glucose control, lipid profiles, and blood pressure on Lp-PLA2 levels in type 2 diabetes mellitus patients

Published:2021-03 Issue: Volume:22 Page:100318
ISSN:2451-8476
Container-title:Obesity Medicine
language:en
Short-container-title:Obesity Medicine

Author:

Kurniawan Liong Boy^ORCID,Rampo Herniaty,Soraya Gita Vita,Adnan Endy,Esa Tenri,Widaningsih Yuyun,Bahrun Uleng,Arif Mansyur

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Lipoprotein-associated phospholipase A2 is linked with poor cardio-metabolic profile in patients with ischemic stroke: a study of effects of statins;Alkuraishy;J. Neurosci. Rural Pract.,2018

2. Phospholipase A2 structure/function, mechanism, and signaling;Burke;J. Lipid Res.,2009

3. Lipoprotein-associated phospholipase A2 is related to plaque stability and is a potential biomarker for acute coronary syndrome;Chung;Yonsei Med. J.,2014

4. Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases;Cojocaru;Maedica (Bucur),2010

5. Association of body composition indexes with cardio-metabolic risk factors;Czeczelewski;Obes. Med.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of probiotic supplementation on lipoprotein-associated phospholipase A2 in type 2 diabetic patients: a randomized double blind clinical controlled trial;Nutrition & Metabolism;2024-01-02

2. Correlation Between Lipoprotein-Related Phospholipase A2 and Metabolic Syndrome;International Journal of General Medicine;2023-12

3. Age- and Sex-Specific Association between Lipoprotein-Related Phospholipase A2 and Cardiometabolic Risk Factors;International Journal of Molecular Sciences;2023-03-30

4. The correlation between lipoprotein associated phospholipase A2 and central overweight status;International Journal of Immunopathology and Pharmacology;2021-01